Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coping Strategies and Experiences of Patients With Crohn's Disease During the COVID-19 Epidemic: A Descriptive Phenomenology Study.

Nursing open·2026
Same author

Long-stranded XNA-cssDNA hybrids for robust data storage.

Science advances·2026
Same author

Fusobacterium varium Exacerbates Neutrophil-driven Intestinal Inflammation Associated with Succinate-SUCNR1-NF-κB Signaling.

Inflammation·2026
Same author

Hepatic Steatosis Severity Prediction in Nonobese Individuals: Machine Learning Model Development and Validation.

Journal of medical Internet research·2026
Same author

Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases.

Research (Washington, D.C.)·2026
Same author

Dual-Spatially Confined Assembly of DNA Nanowall Stiffens Tumor Cells to Enhance Adoptive T-Cell Immunotherapy.

Journal of the American Chemical Society·2026
Same journal

Coronamicroparticle Arrays with Stable Superamphiphobicity.

Small methods·2026
Same journal

Spatial Tail Design in Ionizable Lipids Enhances the Safety and Efficacy of mRNA Delivery.

Small methods·2026
Same journal

Transforming Paper into Plasmonic Sensors: One-Step Fabrication of High-Enhancement SERS Nanosubstrates via Surface Energy Control.

Small methods·2026
Same journal

Analytical Ultracentrifugation in Different High-Density Media Allows to Assess Heterogeneity of mRNA-Lipid Nanoparticles.

Small methods·2026
Same journal

Single Metal Atoms for Energy Storage and Conversion: Recent Advances, Challenges, and Future Perspectives.

Small methods·2026
Same journal

Next-Generation Bioelectronic Neural Interfaces: From Material Design to Closed-Loop Systems.

Small methods·2026
See all related articles
  1. Home
  2. Programmable Circular Single-stranded Dna Acts As Recyclable Anti-mirna Nucleotides To Inhibit Colorectal Cancer.
  1. Home
  2. Programmable Circular Single-stranded Dna Acts As Recyclable Anti-mirna Nucleotides To Inhibit Colorectal Cancer.

Related Experiment Video

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Programmable Circular Single-Stranded DNA Acts as Recyclable Anti-miRNA Nucleotides to Inhibit Colorectal Cancer.

Jinghao Wang1,2, Pengfei Zhang2,3,4, Guang Hu2,5

  • 1Department of Chemistry, University of Science & Technology of China, Hefei, Anhui, China.

Small Methods
|May 13, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

This study introduces circular single-stranded DNA (CssDNA) as a novel platform for colorectal cancer (CRC) therapy. CssDNA effectively targets multiple oncomiRs, restoring tumor suppressor gene expression and offering a stable, recyclable treatment option.

Keywords:
DNA‐based nanomedicinesanti‐miRNA nucleotidecircular single‐stranded DNAmicroRNAmulti‐targeted therapy

More Related Videos

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Experiment Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • MicroRNA (miRNA) therapy shows promise for colorectal cancer (CRC) treatment.
  • Targeting single oncomiRs has limited efficacy due to simultaneous action of multiple oncomiRs in CRC.
  • Current anti-miRNA nucleotide (AMiN) designs face challenges like high synthetic error rates and difficulty in synthesizing long oligonucleotides.

Purpose of the Study:

  • To develop a novel, stable, and recyclable multi-oncomiR targeting platform for colorectal cancer (CRC) therapy.
  • To utilize circular single-stranded DNA (CssDNA) as a superior alternative to conventional AMiNs.
  • To demonstrate the efficacy of CssDNA in degrading multiple oncomiRs and restoring tumor suppressor gene (TSG) expression.

Main Methods:

  • Development of a multi-oncomiR targeting platform using in vivo M13 phage-generated circular single-stranded DNA (CssDNA).
  • CssDNA designed to act as a sponge, attracting and degrading multiple overexpressed oncomiRs in CRC.
  • Assessment of CssDNA's stability, low immunogenicity, recyclability, and efficacy in promoting TSG expression.
  • Main Results:

    • Engineered CssDNA demonstrated high stability, low immunogenicity, and potential for long oligonucleotide synthesis.
    • CssDNA effectively sponged and degraded multiple oncogenic miRNAs (oncomiRs) in colorectal cancer models.
    • Degradation of oncomiRs led to the restoration of tumor suppressor gene (TSG) expression, inhibiting CRC progression.
    • Released CssDNA exhibited recyclability, enabling a second round of therapeutic action.

    Conclusions:

    • Circular single-stranded DNA (CssDNA) presents a promising, stable, and recyclable platform for multi-oncomiR targeting in colorectal cancer (CRC) therapy.
    • This novel CssDNA-based approach offers advantages over traditional anti-miRNA nucleotide (AMiN) designs.
    • The sequence-customizable CssDNA platform holds potential for antagonizing miRNA-mediated repression of tumor suppressor genes in various cancer treatments.